Advanced search
Publication Cover
International Journal of Food Properties Volume 26, 2023 - Issue 1
Submit an article Journal homepage
5,199
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms

Zarina Mushtaqa Department of Food Science, Government College University Faisalabad, Faisalabad, Pakistan
,
Nabeelah Bibi Sadeerb Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit, Mauritius
,
Muzzamal Hussaina Department of Food Science, Government College University Faisalabad, Faisalabad, PakistanORCID Iconhttps://orcid.org/0000-0001-6508-1962
ORCID Icon,
Mahwishc Department of Nutritional Sciences, Government College Women University, Faisalabad, Pakistan
,
Suliman A. Alsagabyd Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, AL-Majmaah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-2242-5638
ORCID Icon,
Muhammad Imrane Department of Food Science and Technology, University of Narowal, Narowal, Pakistan
,
Tamseela Mumtazf Department of Zoology, Government College Women University Faisalabad, Faisalabad, Pakistan
,
Maryam Umara Department of Food Science, Government College University Faisalabad, Faisalabad, Pakistan
,
Ambreen Tauseefg Department of Physiology, CMH, Lahore, Pakistan
,
Waleed Al Abdulmonemh Department of Pathology, College of Medicine, Qassim University, Buraidah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-2984-9262
ORCID Icon,
Tabussam Tufaili Institute of Diet & Nutritional Sciences, The University of Lahore, Lahore, Pakistan;j School of Food and Biological Engineering, Jiangsu University, Zhenjiang, Jiangsu, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7632-5261
ORCID Icon,
Entessar Al Jbawik Agricultural Extension Directorate, MAAR, Damascus, SyriaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1804-1770
ORCID Icon &
Mohamad Fawzi Mahomoodallyb Department of Health Sciences, Faculty of Medicine and Health Sciences, University of Mauritius, Réduit, Mauritius;l Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Saveetha University, Chennai, India;m Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South AfricaCorrespondence[email protected]
 show all
Pages 1914-1939 | Received 27 Feb 2023, Accepted 07 Jul 2023, Published online: 20 Jul 2023

References

  • Bhagwat, S.; Haytowitz, D. B.; Holden, J. M. USDA Database for the Flavonoid Content of Selected Foods Release 3.1. 2014. https://www.ars.usda.gov/ARSUserFiles/80400525/Data/Flav/Flav (Accessed 10 January 2021).
  • Lee, W.-J.; Chen, W.-K.; Wang, C.-J.; Lin, W.-L.; Tseng, T.-H. Apigenin Inhibits HGF-Promoted Invasive Growth and Metastasis Involving Blocking PI3K/Akt Pathway and β4 Integrin Function in MDA-MB-231 Breast Cancer Cells. Toxicol. Appl. Pharmacol. 2008, 226(2), 178–191. DOI: 10.1016/j.taap.2007.09.013.
  • Mullie, P.; Clarys, P.; Deriemaeker, P.; Hebbelinck, M. Estimation of Daily Human Intake of Food Flavonoids. Plant Foods Hum. Nutr. 2007, 62(3), 93–98. DOI: 10.1007/s11130-007-0047-7.
  • Villagómez-Rodríguez, A.; Pérez-Ramos, J.; Esquivel-Campos, A. L.; Pérez-González, C.; Soto-Peredo, C. A.; Pérez-Gutiérrez, S. Anti-Inflammatory Activity of Jefea Gnaphalioides (A. Gray), Astereaceae. BMC Compl. Alternative Med. 2019, 19(1), 1–8. DOI: 10.1186/s12906-019-2654-x.
  • Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget. 2018, 9(6), 7204. DOI: 10.18632/oncotarget.23208.
  • Capelari-Oliveira, P.; Paula, C. A. D.; Rezende, S. A.; Campos, F. T.; Grabe-Guimarães, A.; Lombardi, J. A.; Saúde-Guimarães, D. Anti-Inflammatory Activity of Lychnophora Passerina, Asteraceae (Brazilian “Arnica”). J. Ethnopharmacol. 2011, 135(2), 393–398. DOI: 10.1016/j.jep.2011.03.034.
  • Edwards, J. C.; Cambridge, G. B-Cell Targeting in Rheumatoid Arthritis and Other Autoimmune Diseases. Nat. Rev. Immunol. 2006, 6(5), 394–403. DOI: 10.1038/nri1838.
  • Kim, H. K.; Cheon, B. S.; Kim, Y. H.; Kim, S. Y.; Kim, H. P. Effects of Naturally Occurring Flavonoids on Nitric Oxide Production in the Macrophage Cell Line RAW 264.7 and Their Structure–Activity Relationships. Biochem. Pharmacol. 1999, 58(5), 759–765. DOI: 10.1016/S0006-2952(99)00160-4.
  • Liang, Y.-C.; Huang, Y.-T.; Tsai, S.-H.; Lin-Shiau, S.-Y.; Chen, C.-F.; Lin, J.-K. Suppression of Inducible Cyclooxygenase and Inducible Nitric Oxide Synthase by Apigenin and Related Flavonoids in Mouse Macrophages. Carcinogenesis. 1999, 20(10), 1945–1952. DOI: 10.1093/carcin/20.10.1945.
  • Surh, Y.-J.; Chun, K.-S.; Cha, H.-H.; Han, S. S.; Keum, Y.-S.; Park, K.-K.; Lee, S. S. Molecular Mechanisms Underlying Chemopreventive Activities of Anti-Inflammatory Phytochemicals: Down-Regulation of COX-2 and iNOS Through Suppression of NF-Κb Activation. Mutat. Res. 2001, 480, 243–268. DOI: 10.1016/S0027-5107(01)00183-X.
  • Bhattacharya, S.; Mondal, L.; Mukherjee, B.; Dutta, L.; Ehsan, I.; Debnath, M. C.; Gaonkar, R. H.; Pal, M. M.; Majumdar, S. Apigenin Loaded Nanoparticle Delayed Development of Hepatocellular Carcinoma in Rats. Nanomed. NBM. 2018, 14(6), 1905–1917. DOI: 10.1016/j.nano.2018.05.011.
  • Imran, M.; Aslam Gondal, T.; Atif, M.; Shahbaz, M.; Batool Qaisarani, T.; Hanif Mughal, M.; Salehi, B.; Martorell, M.; Sharifi‐Rad, J. Apigenin as an Anticancer Agent. Phytother. Res. 2020, 34(8), 1812–1828. DOI: 10.1002/ptr.6647.
  • Salmani, J. M. M.; Zhang, X.-P.; Jacob, J. A.; Bao-An, C. Apigenin’s Anticancer Properties and Molecular Mechanisms of Action: Recent Advances and Future Prospectives. Chin. J. Nat. Med. 2017, 15(5), 321–329. DOI: 10.1016/S1875-5364(17)30052-3.
  • Sharma, A.; Ghani, A.; Sak, K.; Tuli, H. S.; Sharma, A. K.; Setzer, W. N.; Sharma, S.; Das, A. K. Probing into Therapeutic Anti-Cancer Potential of Apigenin: Recent Trends and Future Directions. Recent Pat. Inflamm. Allergy Drug Discov. 2019, 13(2), 124–133. DOI: 10.2174/1872213X13666190816160240.
  • Singh, D.; Khan, M. A.; Siddique, H. R. Apigenin, a Plant Flavone Playing Noble Roles in Cancer Prevention via Modulation of Key Cell Signaling Networks. Recent Pat. Anticancer Drug Discov. 2019, 14(4), 298–311. DOI: 10.2174/1574892814666191026095728.
  • Şirin, N.; Elmas, L.; Seçme, M.; Dodurga, Y. Investigation of Possible Effects of Apigenin, Sorafenib and Combined Applications on Apoptosis and Cell Cycle in Hepatocellular Cancer Cells. Gene. 2020, 737, 144428. DOI: 10.1016/j.gene.2020.144428.
  • Salehi, B.; Venditti, A.; Sharifi-Rad, M.; Kręgiel, D.; Sharifi-Rad, J.; Durazzo, A.; Lucarini, M.; Santini, A.; Souto, E. B.; Novellino, E., et al. The Therapeutic Potential of Apigenin. Int. J. Mol. Sci. 2019, 20(6), 1305. DOI: 10.3390/ijms20061305.
  • Meyer, H.; Bolarinwa, A.; Wolfram, G.; Linseisen, J. Bioavailability of Apigenin from Apiin-Rich Parsley in Humans. Ann. Nutr. Metab. 2006, 50(3), 167–172. DOI: 10.1159/000090736.
  • Tang, D.; Chen, K.; Huang, L.; Li, J. Pharmacokinetic Properties and Drug Interactions of Apigenin, a Natural Flavone. Expert. Opin. Drug. Metab Toxicol. 2017, 13(3), 323–330. DOI: 10.1080/17425255.2017.1251903.
  • Wang, M.; Firrman, J.; Liu, L.; Yam, K. A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. Biomed Res. Int. 2019, 2019, 1–18. DOI: 10.1155/2019/7010467.
  • Shankar, E.; Goel, A.; Gupta, K.; Gupta, S. Plant Flavone Apigenin: An Emerging Anticancer Agent. Curr. Pharmacol. Rep. 2017, 3(6), 423–446. DOI: 10.1007/s40495-017-0113-2.
  • Thomas, S. D.; Jha, N. K.; Jha, S. K.; Sadek, B.; Ojha, S. Pharmacological and Molecular Insight on the Cardioprotective Role of Apigenin. Nutrients. 2023, 15(2), 385. DOI: 10.3390/nu15020385.
  • Patel, D.; Shukla, S.; Gupta, S. Apigenin and Cancer Chemoprevention: Progress, Potential and Promise. Int. J. Oncol. 2007, 30(1), 233–245. DOI: 10.3892/ijo.30.1.233.
  • Cardona, F.; Andrés-Lacueva, C.; Tulipani, S.; Tinahones, F. J.; Queipo-Ortuño, M. I. Benefits of Polyphenols on Gut Microbiota and Implications in Human Health. J. Nutr Biochem. 2013, 24(8), 1415–1422. DOI: 10.1016/j.jnutbio.2013.05.001.
  • Chen, T.; Li, L.-P.; Lu, X.-Y.; Jiang, H.-D.; Zeng, S. Absorption and Excretion of Luteolin and Apigenin in Rats After Oral Administration of Chrysanthemum Morifolium Extract. J. Agric. Food. Chem. 2007, 55(2), 273–277. DOI: 10.1021/jf062088r.
  • Gradolatto, A.; Basly, J.-P.; Berges, R.; Teyssier, C.; Chagnon, M.-C.; Siess, M.-H.; Canivenc-Lavier, M.-C. Pharmacokinetics and Metabolism of Apigenin in Female and Male Rats After a Single Oral Administration. Drug Metab. Dispos. 2005, 33(1), 49–54. DOI: 10.1124/dmd.104.000893.
  • Andlauer, W.; Kolb, J.; Fürst, P. Absorption and Metabolism of Genistin in the Isolated Rat Small Intestine. FEBS. Lett. 2000, 475(2), 127–130. DOI: 10.1016/S0014-5793(00)01642-2.
  • Kool, M.; de Haas, M.; Scheffer, G. L.; Scheper, R. J.; van Eijk, M. J.; Juijn, J. A.; Baas, F.; Borst, P. Analysis of Expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-Associated Protein Gene (MRP1), in Human Cancer Cell Lines. Cancer. Res. 1997, 57(16), 3537–3547.
  • Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food Sources and Bioavailability. Am. J. Clin. Nutr. 2004, 79(5), 727–747. DOI: 10.1093/ajcn/79.5.727.
  • Ng, S. P.; Wong, K. Y.; Zhang, L.; Zuo, Z.; Lin, G. Evaluation of the First-Pass Glucuronidation of Selected Flavones in Gut by Caco-2 Monolayer Model. J. Pharm. Pharm. Sci. 2004, 8(1), 1–9.
  • Chen, Z.; Kong, S.; Song, F.; Li, L.; Jiang, H. Pharmacokinetic Study of Luteolin, Apigenin, Chrysoeriol and Diosmetin After Oral Administration of Flos Chrysanthemi Extract in Rats. Fitoterapia. 2012, 83(8), 1616–1622. DOI: 10.1016/j.fitote.2012.09.011.
  • Hao, X.; Cheng, G.; Yu, J.; He, Y.; An, F.; Sun, J.; Cui, F. Study on the Role of Hepatic First-Pass Elimination in the Low Oral Bioavailability of Scutellarin in Rats. Pharmazie. 2005, 60(6), 477–478.
  • Cai, H.; Boocock, D. J.; Steward, W. P.; Gescher, A. J. Tissue Distribution in Mice and Metabolism in Murine and Human Liver of Apigenin and Tricin, Flavones with Putative Cancer Chemopreventive Properties. Cancer Chemother. Pharmacol. 2007, 60(2), 257–266. DOI: 10.1007/s00280-006-0368-5.
  • Das, S.; Rosazza, J. P. Microbial and Enzymatic Transformations of Flavonoids. J. Nat. Prod. 2006, 69(3), 499–508. DOI: 10.1021/np0504659.
  • Wang, S. W.; Kulkarni, K. H.; Tang, L.; Wang, J. R.; Yin, T.; Daidoji, T.; Yokota, H.; Hu, M. Disposition of Flavonoids via Enteric Recycling: UDP-Glucuronosyltransferase (UGT) 1As Deficiency in Gunn Rats is Compensated by Increases in UGT2Bs Activities. J. Pharmacol. Exp. Ther. 2009, 329(3), 1023–1031. DOI: 10.1124/jpet.108.147371.
  • Scalbert, A.; Williamson, G. Dietary Intake and Bioavailability of Polyphenols. J. Nutr. 2000, 130(8), 2073S–2085S. DOI: 10.1093/jn/130.8.2073S.
  • Gradolatto, A.; Canivenc-Lavier, M.-C.; Basly, J.-P.; Siess, M.-H.; Teyssier, C. Metabolism of Apigenin by Rat Liver Phase I and Phase II Enzymes and by Isolated Perfused Rat Liver. Drug Metab. Dispos. 2004, 32(1), 58–65. DOI: 10.1124/dmd.32.1.58.
  • Nielsen, S.; Young, J.; Daneshvar, B.; Lauridsen, S.; Knuthsen, P.; Sandström, B.; Dragsted, L. O. Effect of Parsley (Petroselinum Crispum) Intake on Urinary Apigenin Excretion, Blood Antioxidant Enzymes and Biomarkers for Oxidative Stress in Human Subjects. Br. J. Nutr. 1999, 81(6), 447–455. DOI: 10.1017/S000711459900080X.
  • Bauer, D.; Mazzio, E.; Soliman, K. F. Whole Transcriptomic Analysis of Apigenin on TNFα Immuno-Activated MDA-MB-231 Breast Cancer Cells. Cancer Genom. Proteom. 2019, 16(6), 421–431. DOI: 10.21873/cgp.20146.
  • Hamadou, M. H.; Kerkatou, M.; Gatto, P.; Pancher, M.; Bisio, A.; Inga, A.; Menad, A.; Benayache, S.; Benayache, F.; Ameddah, S. Apigenin Rich-Limonium Duriusculum (de Girard) Kuntze Promotes Apoptosis in HCT116 Cancer Cells. Nat. Prod. Res. 2019, 35(17), 1–5. DOI: 10.1080/14786419.2019.1672070.
  • Qiu, J.-G.; Wang, L.; Liu, W.-J.; Wang, J.-F.; Zhao, E.-J.; Zhou, F.-M.; Ji, X.-B.; Wang, L.-H.; Xia, Z.-K.; Wang, W. Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis. Front. Pharmacol. 2019, 10, 1002. DOI: 10.3389/fphar.2019.01002.
  • Coelho, P. L.; Amparo, J. A.; da Silva, A. B.; da Silva, K. C.; Braga‐de‐Souza, S.; Barbosa, P. R.; Lopes, G. P. D. F.; Costa, S. L. Apigenin from Croton Betulaster Müll Restores the Immune Profile of Microglia Against Glioma Cells. Phytother. Res. 2019, 33(12), 3191–3202. DOI: 10.1002/ptr.6491.
  • Zohreh, B.; Masoumeh, V.; Fakhraddin, N.; Omrani, G. H. Apigenin-Mediated Alterations in Viability and Senescence of SW480 Colorectal Cancer Cells Persist in the Presence of L-Thyroxine. Anti Cancer Agents Med. Chem. 2019, 19(12), 1535–1542. DOI: 10.2174/1871520619666190704102708.
  • Lee, H. H.; Jung, J.; Moon, A.; Kang, H.; Cho, H. Antitumor and Anti-Invasive Effect of Apigenin on Human Breast Carcinoma Through Suppression of IL-6 Expression. Int. J. Mol. Sci. 2019, 20(13), 3143. DOI: 10.3390/ijms20133143.
  • Chien, M.-H.; Lin, Y.-W.; Wen, Y.-C.; Yang, Y.-C.; Hsiao, M.; Chang, J.-L.; Huang, H.-C.; Lee, W.-J. Targeting the SPOCK1-Snail/slug Axis-Mediated Epithelial-To-Mesenchymal Transition by Apigenin Contributes to Repression of Prostate Cancer Metastasis. J. Exp. Clin. Cancer Res. 2019, 38(1), 1–17. DOI: 10.1186/s13046-019-1247-3.
  • Chen, X.; Xu, H.; Yu, X.; Wang, X.; Zhu, X.; Xu, X. Apigenin Inhibits in vitro and in vivo Tumorigenesis in Cisplatin-Resistant Colon Cancer Cells by Inducing Autophagy, Programmed Cell Death and Targeting M-TOR/PI3K/Akt Signalling Pathway. J. Buon. 2019, 24(2), 488–493.
  • Gilardini Montani, M. S.; Cecere, N.; Granato, M.; Romeo, M. A.; Falcinelli, L.; Ciciarelli, U.; D’orazi, G.; Faggioni, A.; Cirone, M. Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 That Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells. Cancers. 2019, 11(5), 703. DOI: 10.3390/cancers11050703.
  • Ittiudomrak, T.; Puthong, S.; Roytrakul, S.; Chanchao, C. α-Mangostin and Apigenin Induced Cell Cycle Arrest and Programmed Cell Death in SKOV-3 Ovarian Cancer Cells. Toxicol. Res. 2019, 35(2), 167–179. DOI: 10.5487/TR.2019.35.2.167.
  • Chen, Z.; Tian, D.; Liao, X.; Zhang, Y.; Xiao, J.; Chen, W.; Liu, Q.; Chen, Y.; Li, D.; Zhu, L. Apigenin Combined with Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through Inhibition of HIF-1α, C-Myc, P-EGFR, and Glucose Metabolism in EGFR L858R+ T790M-Mutated H1975 Cells. Front. Pharmacol. 2019, 10, 260. DOI: 10.3389/fphar.2019.00260.
  • Tong, J.; Shen, Y.; Zhang, Z.; Hu, Y.; Zhang, X.; Han, L. Apigenin Inhibits Epithelial-Mesenchymal Transition of Human Colon Cancer Cells Through NF-Κb/snail Signaling Pathway. Biosci. Rep. 2019, 39(5), 5. DOI: 10.1042/BSR20190452.
  • Qi, Y.; Ding, Z.; Yao, Y.; Ma, D.; Ren, F.; Yang, H.; Chen, A. Novel Triazole Analogs of Apigenin‑7‑Methyl Ether Exhibit Potent Antitumor Activity Against Ovarian Carcinoma Cells via the Induction of Mitochondrial‑Mediated Apoptosis. Exp. Ther. Med. 2019, 17(3), 1670–1676. DOI: 10.3892/etm.2018.7138.
  • Li, Y.-W.; Xu, J.; Zhu, G.-Y.; Huang, Z.-J.; Lu, Y.; Li, X.-Q.; Wang, N.; Zhang, F.-X. Apigenin Suppresses the Stem Cell-Like Properties of Triple-Negative Breast Cancer Cells by Inhibiting YAP/TAZ Activity. Cell. Death Discov. 2018, 4(1), 1–9. DOI: 10.1038/s41420-018-0124-8.
  • Xu, L.; Zhang, Y.; Tian, K.; Chen, X.; Zhang, R.; Mu, X.; Wu, Y.; Wang, D.; Wang, S.; Liu, F. Apigenin Suppresses PD-L1 Expression in Melanoma and Host Dendritic Cells to Elicit Synergistic Therapeutic Effects. J. Exp. Clin. Cancer Res. 2018, 37(1), 1–15. DOI: 10.1186/s13046-018-0929-6.
  • Ozbey, U.; Attar, R.; Romero, M. A.; Alhewairini, S. S.; Afshar, B.; Sabitaliyevich, U. Y.; Hanna‐Wakim, L.; Ozcelik, B.; Farooqi, A. A. Apigenin as an Effective Anticancer Natural Product: Spotlight on TRAIL, WNT/β‐Catenin, JAK‐STAT Pathways, and microRnas. J. Cell. Biochem. 2019, 120(2), 1060–1067. DOI: 10.1002/jcb.27575.
  • Yang, M.; Jiang, Z.-H.; Li, C.-G.; Zhu, Y.-J.; Li, Z.; Tang, Y.-Z.; Ni, C.-L. Apigenin Prevents Metabolic Syndrome in High-Fructose Diet-Fed Mice by Keap1-Nrf2 Pathway. Biomed. Pharmacother. 2018, 105, 1283–1290. DOI: 10.1016/j.biopha.2018.06.108.
  • Malik, S.; Suchal, K.; Khan, S. I.; Bhatia, J.; Kishore, K.; Dinda, A. K.; Arya, D. S. Apigenin Ameliorates Streptozotocin-Induced Diabetic Nephropathy in Rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-Fibronectin Pathways. Am. J. Physiol. Renal Physiol. 2017, 313(2), F414–F422. DOI: 10.1152/ajprenal.00393.2016.
  • Zeng, L.; Zhang, G.; Lin, S.; Gong, D. Inhibitory Mechanism of Apigenin on α-Glucosidase and Synergy Analysis of Flavonoids. J. Agric. Food. Chem. 2016, 64(37), 6939–6949. DOI: 10.1021/acs.jafc.6b02314.
  • Jung, U. J.; Cho, Y.-Y.; Choi, M.-S. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice. Nutrients. 2016, 8(5), 305. DOI: 10.3390/nu8050305.
  • Ren, B.; Qin, W.; Wu, F.; Wang, S.; Pan, C.; Wang, L.; Zeng, B.; Ma, S.; Liang, J. Apigenin and Naringenin Regulate Glucose and Lipid Metabolism, and Ameliorate Vascular Dysfunction in Type 2 Diabetic Rats. Eur. J. Pharmacol. 2016, 773, 13–23. DOI: 10.1016/j.ejphar.2016.01.002.
  • Cazarolli, L. H.; Folador, P.; Moresco, H. H.; Brighente, I. M. C.; Pizzolatti, M. G.; Silva, F. R. M. B. Stimulatory Effect of Apigenin-6-C-β-L-Fucopyranoside on Insulin Secretion and Glycogen Synthesis. Eur. J. Med. Chem. 2009, 44(11), 4668–4673. DOI: 10.1016/j.ejmech.2009.07.001.
  • Panda, S.; Kar, A. Apigenin (4 ‘, 5, 7‐Trihydroxyflavone) Regulates Hyperglycaemia, Thyroid Dysfunction and Lipid Peroxidation in Alloxan‐Induced Diabetic Mice. J. Pharm. Pharmacol. 2007, 59(11), 1543–1548. DOI: 10.1211/jpp.59.11.0012.
  • Su, T.; Huang, C.; Yang, C.; Jiang, T.; Su, J.; Chen, M.; Fatima, S.; Gong, R.; Hu, X.; Bian, Z. Apigenin Inhibits STAT3/CD36 Signaling Axis and Reduces Visceral Obesity. Pharmacol. Res. 2020, 152, 104586. DOI: 10.1016/j.phrs.2019.104586.
  • Okla, M.; Al Madani, J. O.; Chung, S.; Alfayez, M. Apigenin Reverses Interleukin‐1β‐Induced Suppression of Adipocyte Browning via COX2/PGE2 Signaling Pathway in Human Adipocytes. Mol. Nutr Food Res. 2020, 64(1), 1900925. DOI: 10.1002/mnfr.201900925.
  • Gomez-Zorita, S.; Lasa, A.; Abendaño, N.; Fernandez-Quintela, A.; Mosqueda-Solís, A.; Garcia-Sobreviela, M. P.; Arbonés-Mainar, J. M.; Portillo, M. P. Phenolic Compounds Apigenin, Hesperidin and Kaempferol Reduce in vitro Lipid Accumulation in Human Adipocytes. J. Transl. Med. 2017, 15(1), 1–10. DOI: 10.1186/s12967-017-1343-0.
  • Choi, W. H.; Son, H. J.; Jang, Y. J.; Ahn, J.; Jung, C. H.; Ha, T. Y. Apigenin Ameliorates the Obesity‐Induced Skeletal Muscle Atrophy by Attenuating Mitochondrial Dysfunction in the Muscle of Obese Mice. Mol. Nutr Food Res. 2017, 61(12), 1700218. DOI: 10.1002/mnfr.201700218.
  • Kim, M.-A.; Kang, K.; Lee, H.-J.; Kim, M.; Kim, C. Y.; Nho, C. W. Apigenin Isolated from Daphne Genkwa Siebold Et Zucc. Inhibits 3T3-L1 Preadipocyte Differentiation Through a Modulation of Mitotic Clonal Expansion. Life. sci. 2014, 101(1–2), 64–72. DOI: 10.1016/j.lfs.2014.02.012.
  • Lv, Y.; Gao, X.; Shen, W.; Fan, T.; Yao, C.; Ding, M.; Yan, S.; Song, L.; Yan, L. Apigenin Ameliorates HFD-Induced NAFLD Through Regulation of the XO/NLRP3 Pathways. J. Nutr Biochem. 2019, 71, 110–121. DOI: 10.1016/j.jnutbio.2019.05.015.
  • Moharram, F. A.; El Dib, R. A. E. M.; Marzouk, M. S.; El-Shenawy, S. M.; Ibrahim, H. A. New Apigenin Glycoside, Polyphenolic Constituents, Anti-Inflammatory and Hepatoprotective Activities of Gaillardia Grandiflora and Gaillardia pulchella Aerial Parts. Phcog. Mag. 2017, 13(Suppl 2), S244. DOI: 10.4103/pm.pm_344_16.
  • Yue, S.; Xue, N.; Li, H.; Huang, B.; Chen, Z.; Wang, X. Hepatoprotective Effect of Apigenin Against Liver Injury via the Non-Canonical NF-Κb Pathway in vivo and in vitro. Inflammation. 2020, 43(5), 1634–1648. DOI: 10.1007/s10753-020-01238-5.
  • Rašković, A.; Gigov, S.; Čapo, I.; Kusturica, M. P.; Milijašević, B.; Kojić-Damjanov, S.; Martić, N. Antioxidative and Protective Actions of Apigenin in a Paracetamol-Induced Hepatotoxicity Rat Model. Eur. J. Drug Metab. Pharmacokinet. 2017, 42(5), 849–856. DOI: 10.1007/s13318-017-0407-0.
  • Ali, F.; Jyoti, F.; Naz, S.; Siddique, Y. H.; Siddique, Y. H. Protective Effect of Apigenin Against N-Nitrosodiethylamine (NDEA)-Induced Hepatotoxicity in Albino Rats. Mutat. Res. 2014, 767, 13–20. DOI: 10.1016/j.mrgentox.2014.04.006.
  • Mohamed, W. R.; Kotb, A. S.; Abd El‐Raouf, O. M.; Mohammad Fikry, E. Apigenin Alleviated Acetaminophen‐Induced Hepatotoxicity in Low Protein‐Fed Rats: Targeting Oxidative Stress, STAT3, and Apoptosis Signals. J. Biochem. Mol. Toxicol. 2020, 34(5), e22472. DOI: 10.1002/jbt.22472.
  • Tsaroucha, A. K.; Tsiaousidou, A.; Ouzounidis, N.; Tsalkidou, E.; Lambropoulou, M.; Giakoustidis, D.; Chatzaki, E.; Simopoulos, C. Intraperitoneal Administration of Apigenin in Liver Ischemia/Reperfusion Injury Protective Effects. Saudi J. Gastroenterol. 2016, 22(6), 415. DOI: 10.4103/1319-3767.195556.
  • Zhou, R.-J.; Ye, H.; Wang, F.; Wang, J.-L.; Xie, M.-L. Apigenin Inhibits D-Galactosamine/lps-Induced Liver Injury Through Upregulation of Hepatic Nrf-2 and PPARγ Expressions in Mice. Biochem. Biophys. Res. Commun. 2017, 493(1), 625–630. DOI: 10.1016/j.bbrc.2017.08.141.
  • Wang, F.; Liu, J.-C.; Zhou, R.-J.; Zhao, X.; Liu, M.; Ye, H.; Xie, M.-L. Apigenin Protects Against Alcohol-Induced Liver Injury in Mice by Regulating Hepatic CYP2E1-Mediated Oxidative Stress and PPARα-Mediated Lipogenic Gene Expression. Chem. Biol. Interact. 2017, 275, 171–177. DOI: 10.1016/j.cbi.2017.08.006.
  • Feng, X.; Yu, W.; Li, X.; Zhou, F.; Zhang, W.; Shen, Q.; Li, J.; Zhang, C.; Shen, P. Apigenin, a Modulator of PPARγ, Attenuates HFD-Induced NAFLD by Regulating Hepatocyte Lipid Metabolism and Oxidative Stress via Nrf2 Activation. Biochem. Pharmacol. 2017, 136, 136–149. DOI: 10.1016/j.bcp.2017.04.014.
  • Shi, T.; Zhuang, R.; Zhou, H.; Wang, F.; Shao, Y.; Cai, Z. Effect of Apigenin on Protein Expressions of PPARs in Liver Tissues of Rats with Nonalcoholic Steatohepatitis. Zhonghua. gan zang bing za zhi. 2015, 23(2), 124–129. DOI: 10.3760/cma.j.issn.1007-3418.2015.02.010.
  • Zhong, Y.; Jin, C.; Wang, X.; Li, X.; Han, J.; Xue, W.; Wu, P.; Peng, X.; Xia, X. Protective Effects of Apigenin Against 3-MCPD-Induced Renal Injury in Rat. Chem. Biol. Interact. 2018, 296, 9–17. DOI: 10.1016/j.cbi.2018.08.005.
  • Tsalkidou, E. G.; Tsaroucha, A. K.; Chatzaki, E.; Lambropoulou, M.; Papachristou, F.; Trypsianis, G.; Pitiakoudis, M.; Vaos, G.; Simopoulos, C. The Effects of Apigenin on the Expression of Fas/FasL Apoptotic Pathway in Warm Liver Ischemia-Reperfusion Injury in Rats. Biomed Res. Int. 2014, 2014, 1–7. DOI: 10.1155/2014/157216.
  • Zhao, L.; Zhang, J.; Hu, C.; Wang, T.; Lu, J.; Wu, C.; Chen, L.; Jin, M.; Ji, G.; Cao, Q. Apigenin Prevents Acetaminophen-Induced Liver Injury by Activating the SIRT1 Pathway. Front. Pharmacol. 2020, 11, 11. DOI: 10.3389/fphar.2020.00514.
  • Zare, M. F. R.; Rakhshan, K.; Aboutaleb, N.; Nikbakht, F.; Naderi, N.; Bakhshesh, M.; Azizi, Y. Apigenin Attenuates Doxorubicin Induced Cardiotoxicity via Reducing Oxidative Stress and Apoptosis in Male Rats. Life. sci. 2019, 232, 116623. DOI: 10.1016/j.lfs.2019.116623.
  • Li, F.; Lang, F.; Zhang, H.; Xu, L.; Wang, Y.; Zhai, C.; Hao, E. Apigenin Alleviates Endotoxin-Induced Myocardial Toxicity by Modulating Inflammation, Oxidative Stress, and Autophagy. OXID. MED. CELL LONGEV. 2017, 2017, 1–10. DOI: 10.1155/2017/2302896.
  • Liu, H.-J.; Fan, Y.-L.; Liao, H.-H.; Liu, Y.; Chen, S.; Ma, Z.-G.; Zhang, N.; Yang, Z.; Deng, W.; Tang, Q.-Z. Apigenin Alleviates STZ-Induced Diabetic Cardiomyopathy. Mol. Cell. Biochem. 2017, 428(1–2), 9–21. DOI: 10.1007/s11010-016-2913-9.
  • Ren, K.; Jiang, T.; Zhou, H.-F.; Liang, Y.; Zhao, G.-J. Apigenin Retards Atherogenesis by Promoting ABCA1-Mediated Cholesterol Efflux and Suppressing Inflammation. Cell. Physiol. Biochem. 2018, 47(5), 2170–2184. DOI: 10.1159/000491528.
  • Zhou, Z.; Zhang, Y.; Lin, L.; Zhou, J. Apigenin Suppresses the Apoptosis of H9C2 Rat Cardiomyocytes Subjected to Myocardial Ischemia‑Reperfusion Injury via Upregulation of the PI3K/Akt Pathway. Mol. Med. Rep. 2018, 18(2), 1560–1570. DOI: 10.3892/mmr.2018.9115.
  • Gutiérrez-Venegas, G.; González-Rosas, Z. Apigenin Reduce Lipoteichoic Acid-Induced Inflammatory Response in Rat Cardiomyoblast Cells. Arch. Pharm. Res. 2017, 40(2), 240–249. DOI: 10.1007/s12272-016-0756-2.
  • Mahajan, U. B.; Chandrayan, G.; Patil, C. R.; Arya, D. S.; Suchal, K.; Agrawal, Y. O.; Ojha, S.; Goyal, S. N. The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats Mediating Activation of the PPAR-γ Pathway. Int. J. Mol. Sci. 2017, 18(4), 756. DOI: 10.3390/ijms18040756.
  • Feng, Y.; Lu, Y.; Liu, D.; Zhang, W.; Liu, J.; Tang, H.; Zhu, Y. Apigenin-7-O-β-D-(-6 ″-P-Coumaroyl)-Glucopyranoside Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury via Activating AMPK Signaling. Life. sci. 2018, 203, 246–254. DOI: 10.1016/j.lfs.2018.04.048.
  • Zeng, P.; Liu, B.; Wang, Q.; Fan, Q.; Diao, J.-X.; Tang, J.; Fu, X.-Q.; Sun, X.-G. Apigenin Attenuates Atherogenesis Through Inducing Macrophage Apoptosis via Inhibition of AKT Ser473 Phosphorylation and Downregulation of Plasminogen Activator Inhibitor-2. OXID. MED. CELL LONGEV. 2015, 2015, 1–12. DOI: 10.1155/2015/379538.
  • Wang, P.; Sun, J.; Lv, S.; Xie, T.; Wang, X. Apigenin Alleviates Myocardial Reperfusion Injury in Rats by Downregulating MiR-15b. Med. Sci. Monit. 2019, 25, 2764. DOI: 10.12659/MSM.912014.
  • He, Y.; Fang, X.; Shi, J.; Li, X.; Xie, M.; Liu, X. Apigenin Attenuates Pulmonary Hypertension by Inducing Mitochondria-Dependent Apoptosis of PASMCs via Inhibiting the Hypoxia Inducible Factor 1α–KV1. 5 Channel Pathway. Chem. Biol. Interact. 2020, 317, 108942. DOI: 10.1016/j.cbi.2020.108942.
  • Jing, Y.; Chen, R.; Dong, M.; Liu, Y.; Hou, X.; Guo, P.; Li, W.; Lv, J.; Zhang, M. Apigenin Relaxes Rat Intrarenal Arteries, Depresses Ca2±activated Cl− Currents and Augments Voltage-Dependent K+ Currents of the Arterial Smooth Muscle Cells. Biomed. Pharmacother. 2019, 115, 108926. DOI: 10.1016/j.biopha.2019.108926.
  • Yao, H.; Jia, Y.; Xue, Z.; Guo, M.; Lyu, J. Effects of Apigenin on Lipopolysaccharide Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells. Zhonghua. Xin Xue Guan Bing Za Zhi. 2017, 45(4), 323–328. DOI: 10.3760/cma.j.issn.0253-3758.2017.04.013.
  • Zhang, T.; Yan, T.; Du, J.; Wang, S.; Yang, H. Apigenin Attenuates Heart Injury in Lipopolysaccharide-Induced Endotoxemic Model by Suppressing Sphingosine Kinase 1/Sphingosine 1-Phosphate Signaling Pathway. Chem. Biol. Interact. 2015, 233, 46–55. DOI: 10.1016/j.cbi.2014.12.021.
  • Chen, C.; He, H.; Luo, Y.; Zhou, M.; Yin, D.; He, M. Involvement of Bcl-2 Signal Pathway in the Protective Effects of Apigenin on Anoxia/reoxygenation-Induced Myocardium Injury. J. Cardiovasc. Pharmacol. 2016, 67(2), 152–163. DOI: 10.1097/FJC.0000000000000331.
  • Yang, X.; Yang, J.; Hu, J.; Li, X.; Zhang, X.; Li, Z. Apigenin Attenuates Myocardial Ischemia/Reperfusion Injury via the Inactivation of p38 Mitogen‑Activated Protein Kinase. Mol. Med. Rep. 2015, 12(5), 6873–6878. DOI: 10.3892/mmr.2015.4293.
  • Li, W.; Chen, L.; Xiao, Y. Apigenin Protects Against Ischemia-/hypoxia-Induced Myocardial Injury by Mediating Pyroptosis and Apoptosis. Vitro Cell. Dev. Biol. Animal. 2020, 56(4), 307–312. DOI: 10.1007/s11626-020-00434-9.
  • Nayaka, H. B.; Londonkar, R. L.; Umesh, M. K.; Tukappa, A. Antibacterial Attributes of Apigenin, Isolated from Portulaca oleracea L. Int. J. Bacteriol. 2014, 2014, 175851. DOI: 10.1155/2014/175851.
  • Ollila, F.; Halling, K.; Vuorela, P.; Vuorela, H.; Slotte, J. P. Characterization of Flavonoid–Biomembrane Interactions. Arch. Biochem. Biophys. 2002, 399(1), 103–108. DOI: 10.1006/abbi.2001.2759.
  • Górniak, I.; Bartoszewski, R.; Króliczewski, J. Comprehensive Review of Antimicrobial Activities of Plant Flavonoids. Phytochem. Rev. 2019, 18(1), 241–272. DOI: 10.1007/s11101-018-9591-z.
  • Xie, Y.; Yang, W.; Tang, F.; Chen, X.; Ren, L. Antibacterial Activities of Flavonoids: Structure-Activity Relationship and Mechanism. Curr. Med. Chem. 2015, 22(1), 132–149. DOI: 10.2174/0929867321666140916113443.
  • Lee, J.-H.; Regmi, S. C.; Kim, J.-A.; Cho, M. H.; Yun, H.; Lee, C.-S.; Lee, J. Apple Flavonoid Phloretin Inhibits Escherichia coli O157: H7 Biofilm Formation and Ameliorates Colon Inflammation in Rats. Infect. Immun. 2011, 79(12), 4819–4827. DOI: 10.1128/IAI.05580-11.
  • Banerjee, K.; Banerjee, S.; Das, S.; Mandal, M. Probing the Potential of Apigenin Liposomes in Enhancing Bacterial Membrane Perturbation and Integrity Loss. J. Colloid. Interface. Sci. 2015, 453, 48–59. DOI: 10.1016/j.jcis.2015.04.030.
  • Nabavi, S. F.; Khan, H.; D’onofrio, G.; Šamec, D.; Shirooie, S.; Dehpour, A. R.; Argüelles, S.; Habtemariam, S.; Sobarzo-Sanchez, E. Apigenin as Neuroprotective Agent: Of Mice and Men. Pharmacol. Res. 2018, 128, 359–365. DOI: 10.1016/j.phrs.2017.10.008.
  • Balez, R.; Steiner, N.; Engel, M.; Muñoz, S. S.; Lum, J. S.; Wu, Y.; Wang, D.; Vallotton, P.; Sachdev, P.; O’Connor, M. Neuroprotective Effects of Apigenin Against Inflammation, Neuronal Excitability and Apoptosis in an Induced Pluripotent Stem Cell Model of Alzheimer’s Disease. Sci. Rep. 2016, 6(1), 1–16. DOI: 10.1038/srep31450.
  • Sang, Z.; Wang, K.; Shi, J.; Cheng, X.; Zhu, G.; Wei, R.; Ma, Q.; Yu, L.; Zhao, Y.; Tan, Z. Apigenin-Rivastigmine Hybrids as Multi-Target-Directed Liagnds for the Treatment of Alzheimer’s Disease. Eur. J. Med. Chem. 2020, 187, 111958. DOI: 10.1016/j.ejmech.2019.111958.
  • Kim, M.; Jung, J.; Jeong, N. Y.; Chung, H.-J. The Natural Plant Flavonoid Apigenin is a Strong Antioxidant That Effectively Delays Peripheral Neurodegenerative Processes. Anat. Sci. Int. 2019, 94(4), 285–294. DOI: 10.1007/s12565-019-00486-2.
  • Zhao, F.; Dang, Y.; Zhang, R.; Jing, G.; Liang, W.; Xie, L.; Li, Z. Apigenin Attenuates Acrylonitrile-Induced Neuro-Inflammation in Rats: Involved of Inactivation of the TLR4/NF-Κb Signaling Pathway. Int. Immunopharmacol. 2019, 75, 105697. DOI: 10.1016/j.intimp.2019.105697.
  • Zhao, L.; Wang, J.-L.; Liu, R.; Li, X.-X.; Li, J.-F.; Zhang, L. Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model. Molecules. 2013, 18(8), 9949–9965. DOI: 10.3390/molecules18089949.
  • Dourado, N. S.; dos Santos Souza, C.; de Almeida, M. M. A.; da Silva, A. B.; Dos Santos, B. L.; Silva, V. D. A.; De Assis, A. M.; da Silva, J. S.; Souza, D. O.; Costa, M. D. F. D. Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated with Alzheimer’s Disease. Front. Aging Neurosci. 2020, 12, 12. DOI: 10.3389/fnagi.2020.00119.
  • Nikbakht, F.; Khadem, Y.; Haghani, S.; Hoseininia, H.; Sadat, A. M.; Heshemi, P.; Jamali, N. Protective Role of Apigenin Against Aβ25-35 Toxicity via Inhibition of Mitochondrial Cytochrome C Release. Basic Clin. Neurosci. J. 2019, 10(6), 557. DOI: 10.32598/bcn.9.10.385.
  • Liu, W.; Kong, S.; Xie, Q.; Su, J.; Li, W.; Guo, H.; Li, S.; Feng, X.; Su, Z.; Xu, Y., et al. Protective Effects of Apigenin Against 1-Methyl-4-Phenylpyridinium Ion‑Induced Neurotoxicity in PC12 Cells. Int. J. Mol. Med. 2015, 35(3), 739–746. DOI: 10.3892/ijmm.2014.2056.
  • Anusha, C.; Sumathi, T.; Joseph, L. D. Protective Role of Apigenin on Rotenone Induced Rat Model of Parkinson’s Disease: Suppression of Neuroinflammation and Oxidative Stress Mediated Apoptosis. Chem. Biol. Interact. 2017, 269, 67–79. DOI: 10.1016/j.cbi.2017.03.016.
  • Patil, S. P.; Jain, P. D.; Sancheti, J. S.; Ghumatkar, P. J.; Tambe, R.; Sathaye, S. RETRACTED: Neuroprotective and Neurotrophic Effects of Apigenin and Luteolin in MPTP Induced Parkinsonism in Mice. Neuropharmacology. 2014, 86, 192–202. DOI: 10.1016/j.neuropharm.2014.07.012.
  • Izzi, V.; Masuelli, L.; Tresoldi, I.; Sacchetti, P.; Modesti, A.; Galvano, F.; Bei, R. The Effects of Dietary Flavonoids on the Regulation of Redox Inflammatory Networks. Front. Biosci. 2012, 17(7), 2396–2418. DOI: 10.2741/4061.
  • Kim, S.; Joo, Y.-E. Theaflavin Inhibits LPS-Induced IL-6, MCP-1, and ICAM-1 Expression in Bone Marrow-Derived Macrophages Through the Blockade of NF-Κb and MAPK Signaling Pathways. Chonnam Med. J. 2011, 47(2), 104. DOI: 10.4068/cmj.2011.47.2.104.
  • Nicholas, C.; Batra, S.; Vargo, M. A.; Voss, O. H.; Gavrilin, M. A.; Wewers, M. D.; Guttridge, D. C.; Grotewold, E.; Doseff, A. I. Apigenin Blocks Lipopolysaccharide-Induced Lethality in vivo and Proinflammatory Cytokines Expression by Inactivating NF-Κb Through the Suppression of p65 Phosphorylation. J. Immunol. 2007, 179(10), 7121–7127. DOI: 10.4049/jimmunol.179.10.7121.
  • Jeong, G.-S.; Lee, S.-H.; Jeong, S.-N.; Kim, Y.-C.; Kim, E.-C. Anti-Inflammatory Effects of Apigenin on Nicotine-And Lipopolysaccharide-Stimulated Human Periodontal Ligament Cells via Heme Oxygenase-1. Int. Immunopharmacol. 2009, 9(12), 1374–1380. DOI: 10.1016/j.intimp.2009.08.015.
  • Zhang, X.; Wang, G.; Gurley, E. C.; Zhou, H. Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response Through Multiple Mechanisms in Macrophages. Plos One. 2014, 9(9), e107072. DOI: 10.1371/journal.pone.0107072.
  • Aggarwal, B. B.; Vijayalekshmi, R.; Sung, B. Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe. Clin. Cancer Res. 2009, 15(2), 425–430. DOI: 10.1158/1078-0432.CCR-08-0149.
  • Woo, E.-R.; Pokharel, Y. R.; Yang, J. W.; Lee, S. Y.; Kang, K. W. Inhibition of Nuclear Factor-Κb Activation by 2′, 8 ″-Biapigenin. Biol. Pharm. Bull. 2006, 29(5), 976–980. DOI: 10.1248/bpb.29.976.
  • Kowalski, J.; Samojedny, A.; Paul, M.; Pietsz, G.; Wilczok, T. Effect of Apigenin, Kaempferol and Resveratrol on the Expression of Interleukin-1beta and Tumor Necrosis Factor-Alpha Genes in J774. 2 Macrophages. Pharmacol. Rep. 2005, 57(3), 390–394.
  • Seo, H.-S.; Sikder, M. A.; Lee, H. J.; Ryu, J.; Lee, C. J. Apigenin Inhibits Tumor Necrosis Factor-α-Induced Production and Gene Expression of Mucin Through Regulating Nuclear Factor-Kappa B Signaling Pathway in Airway Epithelial Cells. Biomol. Ther. 2014, 22(6), 525. DOI: 10.4062/biomolther.2014.094.
  • Xu, C.; Shen, G.; Chen, C.; Gélinas, C.; Kong, A. N. Suppression of NF-kappaB and NF-kappaB-Regulated Gene Expression by Sulforaphane and PEITC Through IkappaBalpha, IKK Pathway in Human Prostate Cancer PC-3 Cells. Oncogene. 2005, 24(28), 4486–4495. DOI: 10.1038/sj.onc.1208656.
  • Pei, Y.; Yang, L.; Wu, L.; He, H.; Geng, G.; Xu, D.; Chen, H.; Li, Q. Combined Effect of Apigenin and Ferulic Acid on Frozen‐Thawed Boar Sperm Quality. Anim. Sci. J. 2018, 89(7), 956–965. DOI: 10.1111/asj.13009.
  • Dang, Y.; Li, Z.; Luo, B.; Pan, L.; Wei, Q.; Zhang, Y. Protective Effects of Apigenin Against Acrylonitrile-Induced Subchronic Sperm Injury in Rats. Food. Chem. Toxicol. 2017, 109, 517–525. DOI: 10.1016/j.fct.2017.09.025.
  • Shi, X.; Liu, S.; Chen, Y.; Li, F.; Xue, H.; Dang, Y.; Li, Z. Apigenin Affects Semen Parameters in Male Mice. Zhonghua. nan ke xue. 2010, 16(9), 778–782.
  • Pang, L.; Zou, S.; Shi, Y.; Mao, Q.; Chen, Y. Apigenin Attenuates PM2. 5-Induced Airway Hyperresponsiveness and Inflammation by Down-Regulating NF-Κb in Murine Model of Asthma. Int. J. Clin. Exp. Pathol. 2019, 12(10)), 3700.
  • Chen, L.; Zhao, W. Apigenin Protects Against Bleomycin‑Induced Lung Fibrosis in Rats. Exp. Ther. Med. 2016, 11(1), 230–234. DOI: 10.3892/etm.2015.2885.
  • Li, K.-C.; Ho, Y.-L.; Hsieh, W.-T.; Huang, S.-S.; Chang, Y.-S.; Huang, G.-J. Apigenin-7-Glycoside Prevents LPS-Induced Acute Lung Injury via Downregulation of Oxidative Enzyme Expression and Protein Activation Through Inhibition of MAPK Phosphorylation. Int. J. Mol. Sci. 2015, 16(1), 1736–1754. DOI: 10.3390/ijms16011736.
  • Li, R.-R.; Pang, L.-L.; Du, Q.; Shi, Y.; Dai, W.-J.; Yin, K.-S. Apigenin Inhibits Allergen-Induced Airway Inflammation and Switches Immune Response in a Murine Model of Asthma. Immunopharmacol. Immunotoxicol. 2010, 32(3), 364–370. DOI: 10.3109/08923970903420566.
  • Choi, J.-R.; Lee, C.-M.; Jung, I. D.; Lee, J. S.; Jeong, Y.-I.; Chang, J. H.; Park, H.-J.; Choi, I.-W.; Kim, J.-S.; Shin, Y. K., et al. Apigenin Protects Ovalbumin-Induced Asthma Through the Regulation of GATA-3 Gene. Int. Immunopharmacol. 2009, 9(7–8), 918–924. DOI: 10.1016/j.intimp.2009.03.018.
  • Pang, L.; Li, R.; Zhou, L. Inhibitory Effects of Apigenin on the Expression of GATA-3 and Th2 Cytokines in Asthmatic Mice. Zhongguo. Zhong Xi Yi Jie He Za Zhi. 2010, 30(4), 383–387.
  • Avallone, R.; Zanoli, P.; Puia, G.; Kleinschnitz, M.; Schreier, P.; Baraldi, M. Pharmacological Profile of Apigenin, a Flavonoid Isolated from Matricaria Chamomilla. Biochem. Pharmacol. 2000, 59(11), 1387–1394. DOI: 10.1016/S0006-2952(00)00264-1.
  • Weng, L.; Guo, X.; Li, Y.; Yang, X.; Han, Y. Apigenin Reverses Depression-Like Behavior Induced by Chronic Corticosterone Treatment in Mice. Eur. J. Pharmacol. 2016, 774, 50–54. DOI: 10.1016/j.ejphar.2016.01.015.
  • Nakazawa, T.; Yasuda, T.; Ueda, J.; Ohsawa, K. Antidepressant-Like Effects of Apigenin and 2, 4, 5-Trimethoxycinnamic Acid from Perilla Frutescens in the Forced Swimming Test. Biol. Pharm. Bull. 2003, 26(4), 474–480. DOI: 10.1248/bpb.26.474.
  • Han, X. H.; Hong, S. S.; Hwang, J. S.; Lee, M. K.; Hwang, B. Y.; Ro, J. S. Monoamine Oxidase Inhibitory Components from Cayratia Japonica. Arch. Pharm. Res. 2007, 30(1), 13–17. DOI: 10.1007/BF02977772.
  • Chaurasiya, N. D.; Ibrahim, M. A.; Muhammad, I.; Walker, L. A.; Tekwani, B. L. Monoamine Oxidase Inhibitory Constituents of Propolis: Kinetics and Mechanism of Inhibition of Recombinant Human MAO-A and MAO-B. Molecules. 2014, 19(11), 18936–18952. DOI: 10.3390/molecules191118936.
  • Yi, L.-T.; Li, J.-M.; Li, Y.-C.; Pan, Y.; Xu, Q.; Kong, L.-D. Antidepressant-Like Behavioral and Neurochemical Effects of the Citrus-Associated Chemical Apigenin. Life. sci. 2008, 82(13–14), 741–751. DOI: 10.1016/j.lfs.2008.01.007.
  • Li, R.; Zhao, D.; Qu, R.; Fu, Q.; Ma, S. The Effects of Apigenin on Lipopolysaccharide-Induced Depressive-Like Behavior in Mice. Neurosci. Lett. 2015, 594, 17–22. DOI: 10.1016/j.neulet.2015.03.040.
  • Leach, M. J.; Page, A. T. Herbal Medicine for Insomnia: A Systematic Review and Meta-Analysis. Sleep Med. Rev. 2015, 24, 1–12. DOI: 10.1016/j.smrv.2014.12.003.
  • Zick, S. M.; Wright, B. D.; Sen, A.; Arnedt, J. T. Preliminary Examination of the Efficacy and Safety of a Standardized Chamomile Extract for Chronic Primary Insomnia: A Randomized Placebo-Controlled Pilot Study. BMC Compl. Alternative Med. 2011, 11(1), 1–8. DOI: 10.1186/1472-6882-11-78.
  • Das, S.; Das, J.; Paul, A.; Samadder, A.; Khuda-Bukhsh, A. R. Apigenin, a Bioactive Flavonoid from Lycopodium Clavatum, Stimulates Nucleotide Excision Repair Genes to Protect Skin Keratinocytes from Ultraviolet B-Induced Reactive Oxygen Species and DNA Damage. J. Acupunct. Meridian Stud. 2013, 6(5), 252–262. DOI: 10.1016/j.jams.2013.07.002.
  • Choi, S.; Youn, J.; Kim, K.; Joo, D. H.; Shin, S.; Lee, J.; Lee, H. K.; An, I.-S.; Kwon, S.; Youn, H. J. Apigenin Inhibits UVA-Induced Cytotoxicity in vitro and Prevents Signs of Skin Aging in vivo. Int. J. Mol. Med. 2016, 38(2), 627–634. DOI: 10.3892/ijmm.2016.2626.
  • Tong, X.; Mirzoeva, S.; Veliceasa, D.; Bridgeman, B. B.; Fitchev, P.; Cornwell, M. L.; Crawford, S. E.; Pelling, J. C.; Volpert, O. V. Chemopreventive Apigenin Controls UVB-Induced Cutaneous Proliferation and Angiogenesis Through HuR and Thrombospondin-1. Oncotarget. 2014, 5(22), 11413. DOI: 10.18632/oncotarget.2551.
  • Sun, Y.-S.; Qu, W. Dietary Apigenin Promotes Lipid Catabolism, Thermogenesis, and Browning in Adipose Tissues of HFD-Fed Mice. Food. Chem. Toxicol. 2019, 133, 110780. DOI: 10.1016/j.fct.2019.110780.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.